Albert AzoutinLevel VenturesPredicting Mass Spectrum from Molecular GraphsLevel recently invested in Enveda Biosciences’ Series B. We are excited about the company’s potential, and the use of advanced…Mar 24, 2023Mar 24, 2023
Albert AzoutinLevel VenturesUnbundling the Hype (Cycle)Despite being an idealization of reality, the Gartner Hype Cycle is intuitive and digestible, practical and ubiquitous. At times, it is…Apr 5, 2019Apr 5, 2019
Albert AzoutinLevel VenturesThe Actuation GapAt Attached (coming soon) we have been working on developing a platform for autonomous photo and video sharing. Our work in this area has…Feb 20, 2017Feb 20, 2017